JaffeH, PattersonAP, LurieN. Extra oversight for H7N9 experiments. Science. 2013; 341:731.
3.
JohnsonB. Balancing research capability, oversight, and communication post the H5N1 controversy. Appl Biosafety. 2012; 17(1):4–5. Originally published February 29, 2012 online and available from: www.absa.org/pdf/H5N1editorial.pdf.
4.
MalakoffD. Flu controversy spurs research moratorium. Science [Internet]. 2012 [cited 2012];335:387–9:[about 1 p.]. Available from: www.sciencemag.org/content/335/6067/387.
5.
MalakoffD. Critics skeptical as flu scientists argue for controversial H7N9 studies. Science. 2013; 341:601.
6.
U.S. Department of Health and Human Services (HHS) [Internet]. Washington DC: The Department; c2013 [cited 2013]. A framework for guiding U.S. Department of Health and Human Services funding decisions about research proposals with the potential for generating highly pathogenic Avian Influenza H5N1 Viruses that are transmissible among mammals by respiratory droplets; [about 7 p.]. Available from: www.phe.gov/s3/dualuse/Documents/funding-hpai-h5n1.pdf.
7.
U.S. Department of Agriculture (USDA), U.S. Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: CDC; c2013 [cited 2013]. Interim risk assessment and biosafety level recommendations for working with Influenza A (H7N9) Viruses; [about 1 screen]. Available from: www.cdc.gov/flu/avianflu/h7n9/risk-assessment.htm.